Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Europe Neurovascular Devices Market, published by KBV Research, the Europe Neurovascular Devices is expected to grow at a CAGR of 7.6% during the forecast period. The Embolization and Coiling market dominated the Europe Neurovascular Devices Market by Technology in 2015, and would continue to be a dominant market till 2022. The Neurothrombectomy Devices market is expected to witness a CAGR of 9.4% during (2016 - 2022). The Cerebral Balloon Angioplasty & Stenting Systems market is expected to witness a CAGR of 9.6% during (2016 - 2022).
The Germany market dominated the Europe Embolic Coils Market by Country in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 3.1 % during the forecast period. The UK market is expected to witness a CAGR of 2.4% during (2016 - 2022). Additionally, The France market is expected to witness a CAGR of 4.9% during (2016 - 2022). The Embolic Coils market dominated the Germany Embolization and Coiling Market by Type in 2015, and would continue to be a dominant market till 2022.
The Liquid Embolic Agents market is expected to witness a CAGR of 8.1% during (2016 - 2022). The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key influencing factors of the EuropeNeurovascular Devices have been discussed in the report along with the elaborated company profiles of Stryker Corporation, Medtronic Plc, Johnson & Johnson, Terumo Corporation, Abbott Laboratories, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., Microport Scientific Corporation and Medikit Co. Ltd.
Full report : https://www.kbvresearch.com/europe-neurovascular-devices-market/
Research Scope
Global Neurovascular Devices Market
North America Neurovascular Devices Market